Tracking an FDA advisory panel meeting on Covid-19 vaccines and boosters

On the agenda of the FDA's advisory panel on vaccines today: boosters and the possibility of updating the vaccines to better match circulating SARS-CoV-2 strains.

When the Food and Drug Administration last month announced it would be holding another meeting of its panel of outside vaccine experts, it seemed like it would be a general discussion about a second set of Covid-19 boosters: whether they should be administered and, if so, to whom, and when.

That meeting is today, and the timing of it is now more interesting, to say the least. Last week, the FDA authorized another round of boosters for people 50 and older and those with certain immunocompromising conditions. Among the things we’ll be watching for at this meeting of the Vaccines and Related Biological Products Advisory Committee, or VRBPAC, is whether any panelists question that decision, or ask why they weren’t consulted before it was made.

Read the rest…